shortagewatch

Home / Cardiovascular system / Olmesartan Medoxomil and Diuretics

ATC C09DA08 · Agents Acting On The Renin-Angiotensin System

Olmesartan Medoxomil and Diuretics shortage

As of 31 Oct 2026, Olmesartan Medoxomil and Diuretics has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 14 products.

Countries3/5
Products14packs or presentations
Short since31 Aug 20233.2 years ago
Earliest return15 Nov 2026company estimate
No return date11products
Main reasonManufacturing problem

Timeline

ItalySpainBelgium
202420252026OLMESARTAN E IDROCLOROTIAZIDE ZENTIVAOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLANOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLANOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLANOLMESARTAN E IDROCLOROTIAZIDE AUROBINDOOLMESARTAN E IDROCLOROTIAZIDE AUROBINDOOLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBOLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidosOlmetec Plus 40 mg - 25 mg film-coat. tabl. Olmetec Plus 40 mg - 25 mg film-coat. tabl. 28Olmesartan/HCTZ Krka 40 mg - 25 mg film-coatOlmesartan/HCTZ Krka 40 mg - 25 mg film-coat. tabl. 98today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAZENTIVA ITALIA S.R.L.31 Aug 2023not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAZENTIVA ITALIA S.R.L.30 Sep 2023not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN E IDROCLOROTIAZIDE ZENTIVAZENTIVA ITALIA S.R.L.30 Nov 2023not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.16 Sep 2024not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.30 Sep 2024not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.9 Dec 2024not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN E IDROCLOROTIAZIDE AUROBINDOAUROBINDO PHARMA (ITALIA) S.R.L.8 Oct 2026not givenManufacturing problem
Problemi produttivi
ITOLMEGAN announcedDAIICHI SANKYO ITALIA S.P.A.30 Nov 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITOLMEGAN announcedDAIICHI SANKYO ITALIA S.P.A.30 Dec 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITOLMEGAN announcedDAIICHI SANKYO ITALIA S.P.A.30 Dec 2026not givenManufacturing problem
Problemi produttivi
ITOLMEGAN announcedDAIICHI SANKYO ITALIA S.P.A.30 Dec 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ESOLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidosDaiichi Sankyo Espana S.A.5 Oct 202615 Nov 2026Not stated
BEOlmetec Plus 40 mg - 25 mg film-coat. tabl. 28Daiichi Sankyo Belgium13 Aug 20264 Jan 2027Manufacturing problem
Delay in production
BEOlmesartan/HCTZ Krka 40 mg - 25 mg film-coat. tabl. 98KRKA d.d. Novo mesto27 Oct 202630 Nov 2026Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply